The federal 340B Drug Discount Program remained in the spotlight in the past year. Multiple pieces of legislation have been introduced by members of Congress that would alter the program. HRSA and the administration are rumored to be eyeing additional changes. Confusion continues to abound on Medicaid managed care organization billing policies, as states look to make their own regulatory and legal changes. This session looks at these developments and more through the lens of NACHC, a health center executive director who travels the country discussing 340B Program issues (and, occasionally, testifying before Congress), and an attorney who works primarily on 340B Program issues affecting health centers and other grantees. Presenters will also try to anticipate where the program might be going.